We are live on ! Find out more
VM

VV Manager Portfolio holdings

AUM $114M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+59.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$255M
AUM Growth
+$21.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$618M
$222M 87.16%
7,681,133
QTTB icon
2
Q32 Bio
QTTB
$346M
$21.4M 8.39%
42,825
STRO icon
3
Sutro Biopharma
STRO
$391M
$11.3M 4.45%
99,558

Similar funds

VV Manager's Q1 2019 Portfolio in Review

As of Q1 2019, VV Manager held 3 positions worth $255M, up 9.3% from $233M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. VV Manager opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • VV Manager's ten largest holdings make up 100% of its $255M portfolio in Q1 2019.
  • VV Manager opened 0 new positions and closed 0 in Q1 2019.
  • VV Manager's portfolio value rose 9.3% quarter-over-quarter to $255M.

Based on VV Manager's 13F filing for Q1 2019, filed 11 Apr 2019.